Membrane Attack Complex Inhibitor CD59a Protects Against Focal Cerebral Ischemia in Mice

Overview

Journal J Neuroinflammation

Publisher Biomed Central

Date 2010 Mar 6

PMID 20202211

Citations 28

Authors

Denise Harhausen

Uldus Khojasteh

Philip F Stahel

B Paul Morgan

Wilfried Nietfeld

Ulrich Dirnagl

George Trendelenburg

Affiliations

Soon will be listed here.

Abstract

Background: The complement system is a crucial mediator of inflammation and cell lysis after cerebral ischemia. However, there is little information about the exact contribution of the membrane attack complex (MAC) and its inhibitor-protein CD59.

Methods: Transient focal cerebral ischemia was induced by middle cerebral artery occlusion (MCAO) in young male and female CD59a knockout and wild-type mice. Two models of MCAO were applied: 60 min MCAO and 48 h reperfusion, as well as 30 min MCAO and 72 h reperfusion. CD59a knockout animals were compared to wild-type animals in terms of infarct size, edema, neurological deficit, and cell death.

Results And Discussion: CD59a-deficiency in male mice caused significantly increased infarct volumes and brain swelling when compared to wild-type mice at 72 h after 30 min-occlusion time, whereas no significant difference was observed after 1 h-MCAO. Moreover, CD59a-deficient mice had impaired neurological function when compared to wild-type mice after 30 min MCAO.

Conclusion: We conclude that CD59a protects against ischemic brain damage, but depending on the gender and the stroke model used.

Citing Articles

Microglial cell proliferation is regulated, in part, by reactive astrocyte ETB signaling after ischemic stroke.

McInnis J, LeComte M, Reed L, Torsney E, Del Rio-Guerra R, Poynter M Exp Neurol. 2024; 385:115125.

PMID: 39716588 PMC: 11781953. DOI: 10.1016/j.expneurol.2024.115125.

Exploring Structural and Molecular Features of Sciatic Nerve Lesions in Diabetic Neuropathy: Unveiling Pathogenic Pathways and Targets.

Schwarz D, Le Marois M, Sturm V, Peters A, Longuespee R, Helm D Diabetes. 2024; 74(1):65-74.

PMID: 39418320 PMC: 11664024. DOI: 10.2337/db24-0493.

Alterations in ileal transcriptomics during an intestinal barrier challenge in lactating Holstein cows fed a Saccharomyces cerevisiae fermentation product identify potential regulatory processes.

Jiang Q, Palombo V, Sherlock D, Vailati-Riboni M, DAndrea M, Yoon I J Anim Sci. 2023; 101.

PMID: 37616596 PMC: 10576520. DOI: 10.1093/jas/skad277.

Predictive value of soluble CD59 for poor 28-day neurological prognosis and all-cause mortality in patients after cardiopulmonary resuscitation: a prospective observatory study.

Wang L, Li R, Guan X, Liang S, Gong P J Intensive Care. 2023; 11(1):3.

PMID: 36732841 PMC: 9893612. DOI: 10.1186/s40560-023-00653-8.

Placental proteins with predicted roles in fetal development decrease in premature infants.

Schreiner C, Powell T, Palmer C, Jansson T Pediatr Res. 2022; 92(5):1316-1324.

PMID: 35132128 PMC: 9357234. DOI: 10.1038/s41390-022-01942-y.

References

Thomas A, Nockels R, Pan H, Shaffrey C, Chopp M . Progesterone is neuroprotective after acute experimental spinal cord trauma in rats. Spine (Phila Pa 1976). 1999; 24(20):2134-8. DOI: 10.1097/00007632-199910150-00013. View

Kolev M, Tediose T, Sivasankar B, Harris C, Thome J, Morgan B . Upregulating CD59: a new strategy for protection of neurons from complement-mediated degeneration. Pharmacogenomics J. 2009; 10(1):12-9. DOI: 10.1038/tpj.2009.52. View

Holt D, Botto M, Bygrave A, Hanna S, Walport M, Morgan B . Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria. Blood. 2001; 98(2):442-9. DOI: 10.1182/blood.v98.2.442. View

Behl C . Oestrogen as a neuroprotective hormone. Nat Rev Neurosci. 2002; 3(6):433-42. DOI: 10.1038/nrn846. View

Imm M, Feldhoff P, Feldhoff R, Lassiter H . The administration of complement component C9 augments post-ischemic cerebral infarction volume in neonatal rats. Neurosci Lett. 2002; 325(3):175-8. DOI: 10.1016/s0304-3940(02)00271-9. View

Shear D, Galani R, Hoffman S, Stein D . Progesterone protects against necrotic damage and behavioral abnormalities caused by traumatic brain injury. Exp Neurol. 2002; 178(1):59-67. DOI: 10.1006/exnr.2002.8020. View

Tramontini N, Kuipers P, Huber C, Murphy K, Naylor K, Broady A . Modulation of leukocyte recruitment and IL-8 expression by the membrane attack complex of complement (C5b-9) in a rabbit model of antigen-induced arthritis. Inflammation. 2003; 26(6):311-9. DOI: 10.1023/a:1021420903355. View

Xiong Z, Qian W, Suzuki K, McNamara J . Formation of complement membrane attack complex in mammalian cerebral cortex evokes seizures and neurodegeneration. J Neurosci. 2003; 23(3):955-60. PMC: 6741927. View

Cowell R, Plane J, Silverstein F . Complement activation contributes to hypoxic-ischemic brain injury in neonatal rats. J Neurosci. 2003; 23(28):9459-68. PMC: 6740568. View

10.

Katchanov J, Waeber C, Gertz K, Gietz A, Winter B, Bruck W . Selective neuronal vulnerability following mild focal brain ischemia in the mouse. Brain Pathol. 2003; 13(4):452-64. PMC: 8095859. DOI: 10.1111/j.1750-3639.2003.tb00476.x. View

11.

Yamada K, Miwa T, Liu J, Nangaku M, Song W . Critical protection from renal ischemia reperfusion injury by CD55 and CD59. J Immunol. 2004; 172(6):3869-75. DOI: 10.4049/jimmunol.172.6.3869. View

12.

Turnberg D, Botto M, Lewis M, Zhou W, Sacks S, Morgan B . CD59a deficiency exacerbates ischemia-reperfusion injury in mice. Am J Pathol. 2004; 165(3):825-32. PMC: 1618586. DOI: 10.1016/S0002-9440(10)63345-7. View

13.

Baalasubramanian S, Harris C, Donev R, Mizuno M, Omidvar N, Song W . CD59a is the primary regulator of membrane attack complex assembly in the mouse. J Immunol. 2004; 173(6):3684-92. DOI: 10.4049/jimmunol.173.6.3684. View

14.

Bederson J, Pitts L, Tsuji M, Nishimura M, Davis R, Bartkowski H . Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 1986; 17(3):472-6. DOI: 10.1161/01.str.17.3.472. View

15.

Morgan B . Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. Biochem J. 1989; 264(1):1-14. PMC: 1133540. DOI: 10.1042/bj2640001. View

16.

Meri S, Morgan B, Davies A, Daniels R, Olavesen M, Waldmann H . Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology. 1990; 71(1):1-9. PMC: 1384213. View

17.

Roof R, Duvdevani R, Heyburn J, Stein D . Progesterone rapidly decreases brain edema: treatment delayed up to 24 hours is still effective. Exp Neurol. 1996; 138(2):246-51. DOI: 10.1006/exnr.1996.0063. View

18.

Hara H, Huang P, Panahian N, Fishman M, Moskowitz M . Reduced brain edema and infarction volume in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion. J Cereb Blood Flow Metab. 1996; 16(4):605-11. DOI: 10.1097/00004647-199607000-00010. View

19.

Kilgore K, FLORY C, Miller B, Evans V, Warren J . The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells. Am J Pathol. 1996; 149(3):953-61. PMC: 1865152. View

20.

Kilgore K, Schmid E, Shanley T, FLORY C, Maheswari V, Tramontini N . Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation. Am J Pathol. 1997; 150(6):2019-31. PMC: 1858311. View